# Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway

**Authors:** Simon M Carr, Geng Liu, Wojciech Barczak, Hasan Syffudin, Shonagh Munro, Denise Reyna-Jeldes, Iolanda Vendrell, Benedikt Kessler, Adam P Cribbs, Alexander Kanapin, Anastasia Samsonova, Nicholas B La Thangue

PMC · DOI: 10.1093/nar/gkag016 · 2026-01-30

## TL;DR

This study shows how the pRb–E2F pathway coordinates gene transcription and splicing, impacting cell fate and cancer.

## Contribution

The study reveals distinct yet coordinated transcription and splicing gene networks regulated by the pRb–E2F pathway.

## Key findings

- Transcription and splicing gene networks regulated by pRb–E2F are largely non-overlapping.
- E2F1 interacts with SRSF2 and HNRNPC to mediate alternative splicing events.
- E2F1's splicing activity is observed during the cell cycle and DNA damage response.

## Abstract

The pRb–E2F pathway is involved in mediating diverse cell fates, and oncogenic disruption of the pathway is regarded as a hallmark of cancer. Recent studies highlighted the pRb–E2F axis as a regulator of a large gene network which includes RNA splicing and transcription targets. Here, we have performed a deep genome-wide analysis of differentially expressed genes (DEGs) and alternatively spliced (AS) RNA targets which highlighted broadly non-overlapping networks of genes that are independently regulated by the pRb–E2F pathway. Individual pathway components, including E2F1, pRb, and PRMT5, either as single or combined knockouts, were found to influence DEG and AS networks but to different extents. An analysis of the E2F1 interactome revealed SRSF2 and HNRNPC as candidate proteins that were able to functionally assist E2F1 in mediating AS events. Moreover, E2F1 AS activity was evident as cells progress through the cell cycle and during the DNA damage response, and apparent in tumour models. Our results highlight gene networks where transcription and splicing are linked and coordinated by the pRb–E2F pathway, and further establish the widespread influence that pRb, E2F1, and PRMT5 have on regulating biological diversity through RNA splicing control.

Graphical Abstract

## Linked entities

- **Genes:** RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925], E2F1 (E2F transcription factor 1) [NCBI Gene 1869], PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419], SRSF2 (serine and arginine rich splicing factor 2) [NCBI Gene 6427], HNRNPC (heterogeneous nuclear ribonucleoprotein C) [NCBI Gene 3183]

## Full-text entities

- **Genes:** Rb1 (RB transcriptional corepressor 1) [NCBI Gene 19645] {aka Rb, Rb-1, p110-RB1, pRb, pp105}, MPC1 (mitochondrial pyruvate carrier 1) [NCBI Gene 51660] {aka BRP44L, CGI-129, MPYCD, SLC54A1}, tsn.L (translin L homeolog) [NCBI Gene 380118] {aka bclf-1, rchf1, rehf-1, tbrbp, trsln, tsn}, ELK4 (ETS transcription factor ELK4) [NCBI Gene 2005] {aka SAP1}, HNRNPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1) [NCBI Gene 3181] {aka HNRNPA2, HNRNPB1, HNRPA2, HNRPA2B1, HNRPB1, IBMPFD2}, VCAN (versican) [NCBI Gene 1462] {aka CSPG2, ERVR, GHAP, PG-M, WGN, WGN1}, snd1.S (staphylococcal nuclease and tudor domain containing protein 1 S homeolog) [NCBI Gene 379293] {aka snd1, snd1-a, snd1-b, tdrd11}, TRPT1 (tRNA phosphotransferase 1) [NCBI Gene 83707], TFDP2 (transcription factor Dp-2) [NCBI Gene 7029] {aka DP2}, THBS1 (thrombospondin 1) [NCBI Gene 7057] {aka THBS, THBS-1, TSP, TSP-1, TSP1}, HNRNPH1 (heterogeneous nuclear ribonucleoprotein H1) [NCBI Gene 3187] {aka HNRPH, HNRPH1, NEDCDS, hnRNPH}, SORBS1 (sorbin and SH3 domain containing 1) [NCBI Gene 10580] {aka CAP, FLAF2, R85FL, SH3D5, SH3P12, SORB1}, hnrnpa2b1.S (heterogeneous nuclear ribonucleoprotein A2/B1 S homeolog) [NCBI Gene 380082] {aka hnrnpa2, hnrnpa2b1, hnrnpb1, hnrpa2, hnrpa2b1, hnrpb1}, RUSC2 (RUN and SH3 domain containing 2) [NCBI Gene 9853] {aka Iporin, MRT61}, gapdh.S (glyceraldehyde-3-phosphate dehydrogenase S homeolog) [NCBI Gene 380259] {aka gapd, gapdh, gapdh.L}, TP53 (tumor protein p53) [NCBI Gene 7157] {aka BCC7, BMFS5, LFS1, P53, TRP53}, CCNA2 (cyclin A2) [NCBI Gene 890] {aka CCN1, CCNA}, METTL6 (methyltransferase 6, tRNA N3-cytidine) [NCBI Gene 131965] {aka hMETTL6}, TUBA1B (tubulin alpha 1b) [NCBI Gene 10376] {aka K-ALPHA-1}, AGFG1 (ArfGAP with FG repeats 1) [NCBI Gene 3267] {aka HRB, RAB, RIP}, LINC02605 (long intergenic non-protein coding RNA 2605) [NCBI Gene 112935892] {aka AS, IL-7, IL-7-AS}, PRMT5 (protein arginine methyltransferase 5) [NCBI Gene 10419] {aka HRMT1L5, HSL7, IBP72, JBP1, SKB1, SKB1Hs}, vcan.L (versican L homeolog) [NCBI Gene 100037127] {aka Xversican, vcan}, pcbp3.L (poly(rC) binding protein 3 L homeolog) [NCBI Gene 399399] {aka hnRNP-E2, pcbp2}, RB1 (RB transcriptional corepressor 1) [NCBI Gene 5925] {aka OSRC, PPP1R130, RB, p105-Rb, p110-RB1, pRb}, hnrnpc.L (heterogeneous nuclear ribonucleoprotein C (C1/C2) L homeolog) [NCBI Gene 397793] {aka hnRNP C, hnrnp, hnrnpc, hnrpc, snrpc}, REV3L (REV3 like, DNA directed polymerase zeta catalytic subunit) [NCBI Gene 5980] {aka POLZ, REV3}, thbs1.L (thrombospondin 1 L homeolog) [NCBI Gene 379508] {aka thbs, thbs-1, thbs1, tsp, tsp-1, tsp1}, E2F1 (E2F transcription factor 1) [NCBI Gene 1869] {aka E2F-1, RBAP1, RBBP3, RBP3}, TLR5 (toll like receptor 5) [NCBI Gene 7100] {aka MELIOS, SLE1, SLEB1, TIL3}, ung.L (uracil DNA glycosylase L homeolog) [NCBI Gene 443838] {aka ung}, ccna2.S (cyclin A2 S homeolog) [NCBI Gene 397933] {aka Cyclin-A2, ccna2}, mcm3.L (minichromosome maintenance complex component 3 L homeolog) [NCBI Gene 397821] {aka mcm3, xmcm3}, CDC6 (cell division cycle 6) [NCBI Gene 990] {aka CDC18L, HsCDC18, HsCDC6, MGORS5}, JTB (jumping translocation breakpoint) [NCBI Gene 10899] {aka HJTB, HSPC222, PAR, hJT}, SRPRA (SRP receptor subunit alpha) [NCBI Gene 6734] {aka DP, SRPR, Sralpha}, OXSR1 (oxidative stress responsive kinase 1) [NCBI Gene 9943] {aka OSR1}, TFDP1 (transcription factor Dp-1) [NCBI Gene 7027] {aka DILC, DP1, DRTF1, Dp-1}, TRMT1 (tRNA methyltransferase 1) [NCBI Gene 55621] {aka MRT68, TRM1, hTRM1}, RCAN1 (regulator of calcineurin 1) [NCBI Gene 1827] {aka ADAPT78, CSP1, DSCR1, MCIP1}, prmt5.L (protein arginine methyltransferase 5 L homeolog) [NCBI Gene 495515] {aka hsl7, prmt5}, trmt1.L (tRNA methyltransferase 1 L homeolog) [NCBI Gene 100158298] {aka trmt1}, snrpe.L (small nuclear ribonucleoprotein polypeptide E L homeolog) [NCBI Gene 443996] {aka b-raf, sm-e, sme, snrpe}, tfdp1.L (transcription factor Dp-1 L homeolog) [NCBI Gene 494744] {aka dp-1, dp1, drtf1, tfdp1, tfdp1-a, tfdp1-b}, rcan1.L (regulator of calcineurin 1 L homeolog) [NCBI Gene 379550] {aka adapt78, csp1, dsc1, dscr1, mcip1, rcan1}, rtn4.S (reticulon 4 S homeolog) [NCBI Gene 398819] {aka Nogo, Nogo-A, rtn4, rtn4-a, rtn4-b, rtn4a}, CCNE1 (cyclin E1) [NCBI Gene 898] {aka CCNE, pCCNE1}, SAXO6 (stabilizer of axonemal microtubules 6) [NCBI Gene 56890] {aka MDM1}, SRSF2 (serine and arginine rich splicing factor 2) [NCBI Gene 6427] {aka PR264, SC-35, SC35, SFRS2, SFRS2A, SRp30b}, CCDC17 (coiled-coil domain containing 17) [NCBI Gene 149483], CCNE2 (cyclin E2) [NCBI Gene 9134] {aka CYCE2}, IL18R1 (interleukin 18 receptor 1) [NCBI Gene 8809] {aka CD218a, CDw218a, IL-18R, IL-18R-alpha, IL-18Ralpha, IL-1Rrp}, CLEC4D (C-type lectin domain family 4 member D) [NCBI Gene 338339] {aka CD368, CLEC-6, CLEC6, CLECSF8, Dectin-3, MCL}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, DEPDC4 (DEP domain containing 4) [NCBI Gene 120863] {aka DEP.4}, e2f1.L (E2F transcription factor 1 L homeolog) [NCBI Gene 100036852] {aka e2f1, xE2F}, u2af1.S (U2 small nuclear RNA auxiliary factor 1 S homeolog) [NCBI Gene 734926] {aka u2af1}, srsf1.L (serine/arginine-rich splicing factor 1 L homeolog) [NCBI Gene 399226] {aka asf, sf2, sf2p33, sfrs1, srp30a, srsf1}, PCNA (proliferating cell nuclear antigen) [NCBI Gene 5111] {aka ATLD2}, actb.L (actin, beta L homeolog) [NCBI Gene 398459] {aka actb, g-actin}
- **Diseases:** mycoplasma (MESH:D009175), colorectal cancer (MESH:D015179), lung adenocarcinoma (MESH:D000077192), pancreatic cancer (MESH:D010190), lung tumour (MESH:D008175), Colon26 tumours (MESH:D009369), SD (MESH:D012735), AS (MESH:C536589)
- **Chemicals:** DMSO (MESH:D004121), ethanol (MESH:D000431), streptomycin (MESH:D013307), propidium iodide (MESH:D011419), EDTA (MESH:D004492), penicillin (MESH:D010406), Igepal CA-630 (MESH:C010615), Laemmli buffer (MESH:C088816), glycerol (MESH:D005990), AEBSF (MESH:C002010), SDMe (MESH:C024917), PBS (MESH:D007854), H2O (MESH:D014867), NaCl (MESH:D012965), SYBR Green (MESH:C098022), Oligofectamine (MESH:C484027), SDS (MESH:D012967), NT2 (MESH:C068951), LLY-283 (MESH:C000723530), Etop (MESH:D005047), TRIzol (MESH:C411644), NaF (MESH:D012969), agarose (MESH:D012685), bromophenol blue (MESH:D001978), HCl (MESH:D006851), MgCl2 (MESH:D015636), HU (MESH:D006918), FLASH (-), Isopropanol (MESH:D019840), dUTP (MESH:C027078), S (MESH:D013455), JNJ-64619178 (MESH:C000631033), thymidine (MESH:D013936)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** PANC1 — Homo sapiens (Human), Pancreatic ductal adenocarcinoma, Cancer cell line (CVCL_0480), Cr — Mus musculus (Mouse), Hybridoma (CVCL_A0AJ), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), S2B — Homo sapiens (Human), Childhood T acute lymphoblastic leukemia, Cancer cell line (CVCL_1860), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), K562 — Homo sapiens (Human), Blast phase chronic myelogenous leukemia, BCR-ABL1 positive, Cancer cell line (CVCL_0004), HCT116 — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0291), HEK293 — Homo sapiens (Human), Transformed cell line (CVCL_0045), Colon26 — Mus musculus (Mouse), Mouse colon adenocarcinoma, Cancer cell line (CVCL_0240), MCF7 — Homo sapiens (Human), Invasive breast carcinoma of no special type, Cancer cell line (CVCL_0031)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12856215/full.md

---
Source: https://tomesphere.com/paper/PMC12856215